Delivery Order SPE2DB20D2014-SPE2DB24FC05P
- Not listed
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of the pharmaceutical product Contrave ER 8-90 mg tablet in 120-count packages. The $1,029.78 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which manages medical supplies and equipment for the Department of Defense. This order is a task issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S to the U.S. government. The $8,784.34 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award worth $14,306.34 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the procurement of 4,564,292,568 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. This contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,485.66 Firm Fixed Price Delivery Order contract is for the supply of Contrave ER 8/90mg 120 count medication. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $9,560.31 firm fixed-price delivery order is for the supply of 120 tablets of the prescription drug Contrave ER 8-90 MG. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,976.75 delivery order is for the supply of 120 tablets of the drug Contrave ER 8-90 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the provision of Contrave ER 8-90 mg tablets. The Delivery Order, valued at $6,752.60, was awarded on a Firm Fixed Price basis without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,216.00 Delivery Order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the drug Contrave ER 8-90 mg tablets. The delivery order, valued at $5,367.46, is a firm-fixed-price contract with an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FC05PDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $12,488.58 Firm Fixed Price delivery order is for the provision of 4,564,742,861 units of the prescription drug Contrave ER 8-90 mg Tablet, with a completion date of May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts highlight Amerisourcebergen's significant role as a key supplier of critical pharmaceutical and medical commodities to various federal agencies, supporting their mission to provide essential healthcare services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 5/29/24 |